Access

The Medicare Prospective Payment System helps ensure equitable access to Velphoro for patients on dialysis1

Customized formulary for each dialysis organization

Minimal paperwork for you and your staff

No additional copay or coinsurance for most patients*

Delivery by mail to assist adherence

Prescribe Velphoro

Choose the phosphate binder you’ve trusted for proven results

 

*Includes fee-for-service patients receiving phosphate binder therapy through their dialysis organization. Out-of-pocket costs are based on the patient's medical health plan coinsurance structure.

 

Reference: 1. Centers for Medicare & Medicaid Services. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, Conditions for Coverage for End-Stage Renal Disease Facilities, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model. Fed Regist. 2024;89(218):89084-89213. 42 CFR Parts 410, 413, 494, and 512. https://www.govinfo.gov/content/pkg/FR-2024-11-12/pdf/2024-25486.pdf